Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cells

Sandra Van Schaeybroeck; Joan Kyula; D. Kelly; A. Karaiskou-McCaul; Susan Stokesberry; E. Van Cutsem; Daniel Longley; Patrick Johnston

doi:10.1158/1535-7163.MCT-05-0446

Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cells

Sandra Van Schaeybroeck, Joan Kyula, D. Kelly, A. Karaiskou-McCaul, Susan Stokesberry, E. Van Cutsem, Daniel Longley, Patrick Johnston

Research output: Contribution to journal › Article › peer-review

88 Citations (Scopus)

Original language	English
Pages (from-to)	1154-1165
Number of pages	12
Journal	Molecular Cancer Therapeutics
Volume	5(5)
Issue number	5
DOIs	https://doi.org/10.1158/1535-7163.MCT-05-0446
Publication status	Published - May 2006

ASJC Scopus subject areas

Oncology
Drug Discovery
Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1535-7163.MCT-05-0446

Cite this

Van Schaeybroeck, S., Kyula, J., Kelly, D., Karaiskou-McCaul, A., Stokesberry, S., Van Cutsem, E., Longley, D., & Johnston, P. (2006). Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cells. Molecular Cancer Therapeutics, 5(5)(5), 1154-1165. https://doi.org/10.1158/1535-7163.MCT-05-0446

@article{34b354fc32364238a395b502a1f9755e,

title = "Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cells",

author = "{Van Schaeybroeck}, Sandra and Joan Kyula and D. Kelly and A. Karaiskou-McCaul and Susan Stokesberry and {Van Cutsem}, E. and Daniel Longley and Patrick Johnston",

year = "2006",

month = may,

doi = "10.1158/1535-7163.MCT-05-0446",

language = "English",

volume = "5(5)",

pages = "1154--1165",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "5",

}

Van Schaeybroeck, S, Kyula, J, Kelly, D, Karaiskou-McCaul, A, Stokesberry, S, Van Cutsem, E, Longley, D & Johnston, P 2006, 'Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cells', Molecular Cancer Therapeutics, vol. 5(5), no. 5, pp. 1154-1165. https://doi.org/10.1158/1535-7163.MCT-05-0446

TY - JOUR

T1 - Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cells

AU - Van Schaeybroeck, Sandra

AU - Kyula, Joan

AU - Kelly, D.

AU - Karaiskou-McCaul, A.

AU - Stokesberry, Susan

AU - Van Cutsem, E.

AU - Longley, Daniel

AU - Johnston, Patrick

PY - 2006/5

Y1 - 2006/5

UR - http://www.scopus.com/inward/record.url?scp=33745059265&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-05-0446

DO - 10.1158/1535-7163.MCT-05-0446

M3 - Article

C2 - 16731747

SN - 1535-7163

VL - 5(5)

SP - 1154

EP - 1165

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

IS - 5

ER -

Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cells

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this